Literature DB >> 3709195

Transport of critically ill adults.

J Ehrenwerth, S Sorbo, A Hackel.   

Abstract

Interhospital transport can be hazardous because of rapid changes in a patient's physiologic status and the use of monitoring systems. A retrospective study evaluated the first 204 critically ill adult patients transported from community hospitals to Stanford Medical Center by a special transport team. To relate the risk of transport to severity of illness, a retrospective scoring system was devised. Sixty-one percent (n = 125) of the patients were at high risk for transport. The patients were stabilized at the referring hospital, and invasive monitoring was used as mandated by the patient's condition. The average transport distance was 133 km, and the average duration of transport was 4.38 h. One hundred and five patients (51.5%) were transported by air, and the remaining patients were transported by surface ambulance. All patients survived the transport, and 71.6% were eventually discharged from the hospital. Hospital mortality correlated with the risk-scoring system (p less than .01) and increased five-fold as severity of illness increased. This study demonstrates that, with appropriate hemodynamic stabilization and monitoring, severely ill patients can be transported safely.

Entities:  

Mesh:

Year:  1986        PMID: 3709195     DOI: 10.1097/00003246-198606000-00005

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  13 in total

1.  Critical care in the emergency department: patient transfer.

Authors:  M J G Dunn; C L Gwinnutt; A J Gray
Journal:  Emerg Med J       Date:  2007-01       Impact factor: 2.740

2.  Secondary insults during intrahospital transport of neurosurgical intensive care patients.

Authors:  A Bekar; Z Ipekoglu; K Türeyen; H Bilgin; G Korfali; E Korfali
Journal:  Neurosurg Rev       Date:  1998       Impact factor: 3.042

3.  Provision of facilities for secondary transport of seriously ill patients in the United Kingdom.

Authors:  I H Wright; J C McDonald; P N Rogers; I M Ledingham
Journal:  Br Med J (Clin Res Ed)       Date:  1988-02-20

Review 4.  Secondary transport of the critically ill and injured adult.

Authors:  A Gray; S Bush; S Whiteley
Journal:  Emerg Med J       Date:  2004-05       Impact factor: 2.740

5.  Incidents relating to the intra-hospital transfer of critically ill patients. An analysis of the reports submitted to the Australian Incident Monitoring Study in Intensive Care.

Authors:  Ursula Beckmann; Donna M Gillies; Sean M Berenholtz; Albert W Wu; Peter Pronovost
Journal:  Intensive Care Med       Date:  2004-02-26       Impact factor: 17.440

6.  Physician-accompanied transport of surgical intensive care patients.

Authors:  M J Girotti; G Pagliarello; T R Todd; W Demajo; J Cain; P Walker; A Patterson
Journal:  Can J Anaesth       Date:  1988-05       Impact factor: 5.063

Review 7.  Outcomes of interfacility critical care adult patient transport: a systematic review.

Authors:  Eddy Fan; Russell D MacDonald; Neill K J Adhikari; Damon C Scales; Randy S Wax; Thomas E Stewart; Niall D Ferguson
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

Review 8.  Transferring the critically ill patient: are we there yet?

Authors:  Joep M Droogh; Marije Smit; Anthony R Absalom; Jack J M Ligtenberg; Jan G Zijlstra
Journal:  Crit Care       Date:  2015-02-20       Impact factor: 9.097

9.  Routine follow-up cranial computed tomography for deeply sedated, intubated, and ventilated multiple trauma patients with suspected severe head injury.

Authors:  Thomas Erik Wurmb; Stefan Schlereth; Markus Kredel; Ralf M Muellenbach; Christian Wunder; Jörg Brederlau; Norbert Roewer; Werner Kenn; Ekkehard Kunze
Journal:  Biomed Res Int       Date:  2014-01-20       Impact factor: 3.411

Review 10.  Pro/con debate: do the benefits of regionalized critical care delivery outweigh the risks of interfacility patient transport?

Authors:  Jeffrey M Singh; Russell D MacDonald
Journal:  Crit Care       Date:  2009-08-10       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.